We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Spindle Replacement Therapy Prevents Transmission of Inherited Mitochondrial Diseases

By LabMedica International staff writers
Posted on 09 Sep 2009
In the future, inherited diseases caused by mutations in mitochondrial DNA (mtDNA) may be avoided by the use of a novel gene therapy technique that transfers a defective egg's genome into an enucleated egg with healthy mtDNA.

Approximately 150 diseases, including certain forms of cancer, diabetes, infertility, myopathies, and neurodegenerative diseases, are caused by defective mtDNA; and approximately one out of every 200 children is born with mitochondrial mutations.

To correct this situation, investigators from the Oregon Health & Science University (Beaverton, USA) worked with monkeys as a model of human inherited mitochondrial disease. More...
They reported in the August 26, 2009, online edition of the journal Nature that by employing a technique called spindle replacement they could remove the genetic material from an egg with mutated mtDNA and transfer it to an enucleated egg with healthy mtDNA.

The experiment was performed using eggs from two different monkeys. After transfer of the genetic material, the reconstructed eggs with the mitochondrial replacement were capable of supporting normal fertilization, embryo development, and produced healthy offspring. DNA screening studies of the baby monkeys that developed from the reconstructed eggs showed that they were genetically the offspring of the egg donor, but that their mitochondria were from the enucleated egg. No mtDNA from the donor egg could be detected in the offspring.

"In theory, this research has demonstrated that it is possible to use this therapy in mothers carrying mitochondrial DNA diseases so that we can prevent those diseases from being passed on to their offspring,” said senior author Dr. Shoukhrat Mitalipov, assistant scientist in reproductive biology at the Oregon Health and Science University. "We believe that with the proper governmental approvals, our work can rapidly be translated into clinical trials for humans, and, eventually, approved therapies.”

Related Links:

Oregon Health & Science University




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.